Document Detail


Response of solitary psoriatic plaques to experimental application of podophyllotoxin.
MedLine Citation:
PMID:  3525264     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 16-week double-blind study of parallel groups was carried out in the treatment of 152 patients suffering from stable psoriasis vulgaris. Podophyllotoxin was applied once daily at three different concentrations in an ointment base, namely 0.1, 0.25 and 0.5%. One stable psoriatic lesion was selected and monitored during the study course. All three concentrations of podophyllotoxin induced a statistically highly significant improvement (p less than 0.001) of the selected lesions. There was statistically highly significant difference between the treated and control lesions already after 2 weeks of treatment (p greater than 0.001), and this difference increased further during the study course. Eleven patients experienced adverse reactions - severe skin rash - spontaneously reported by the patients.
Authors:
A Lassus; B Rosen
Related Documents :
9878984 - Treatment of warts with topical pyruvic acid: with and without added 5-fluorouracil.
18221454 - Photodynamic therapy in the treatment of actinic keratosis.
8957334 - Psoralen plus uva protocol for compositae photosensitivity.
15379774 - Efalizumab in the treatment of psoriasis.
22459744 - Carotid endarterectomy is more cost-effective than carotid artery stenting.
19569064 - Two-year outcomes of the sirolimus-eluting stent according to unprotected left main les...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Dermatologica     Volume:  172     ISSN:  0011-9075     ISO Abbreviation:  Dermatologica     Publication Date:  1986  
Date Detail:
Created Date:  1986-09-25     Completed Date:  1986-09-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0211607     Medline TA:  Dermatologica     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  319-22     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Podophyllotoxin / therapeutic use*
Psoriasis / drug therapy*
Chemical
Reg. No./Substance:
518-28-5/Podophyllotoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Studies on estrogen receptor in normal and cancerous human uterine endometrium by immunological met...
Next Document:  Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and...